TCM
NUVA

Tamarack Capital Management’s NuVasive, Inc. NUVA Stock Holding History

Tamarack Capital Management’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-25,000
Closed -$1.21M – 24
2015
Q3 		$1.21M Buy
+25,000
New +$1.29M 0.14% 31

Other funds holding NUVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tamarack Capital Management's NUVA Position: Q4 2015 in Review

Tamarack Capital Management sold out of NuVasive, Inc. (NUVA) in Q4 2015, closing a stake of 25,000 shares — an estimated $1.21M sold.

Tamarack Capital Management first reported a position in NUVA in Q3 2015 and held it in 1 quarter. The position peaked at $1.21M in Q3 2015. 233 funds tracked by Wall St. Rank hold NUVA as of Q4 2015.

  • Tamarack Capital Management reported no remaining NuVasive, Inc. position as of Q4 2015 after selling out during the quarter.
  • Tamarack Capital Management sold 25,000 NuVasive, Inc. shares in Q4 2015, an estimated $1.21M.
  • Tamarack Capital Management first reported a position in NuVasive, Inc. in Q3 2015 and held it in 1 quarter.
  • Tamarack Capital Management's NuVasive, Inc. position peaked at $1.21M in Q3 2015.
  • 233 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2015.

Based on Tamarack Capital Management's 13F filing for Q4 2015.